eduKateSG · Why Science?
Turn vision into measurable evidence—connecting optics, myopia, cohorts, imaging, artificial intelligence, glaucoma, retina, cornea, therapeutics, devices, trials and patient-centred translation
A fact-checked guide to the Singapore Eye Research Institute, ophthalmic science, myopia, population studies, imaging, AI, devices, therapeutics, clinical evidence and careers.
Singapore National Eye Centre says SERI was established in 1997 as Singapore’s national research institute for ophthalmic and vision research, with a mission focused on preventing blindness, low vision and major eye diseases relevant to Singaporeans and Asians.
SERI’s official institutional page says it bridges healthcare clusters, opens facilities and resources to researchers across Singapore, and is affiliated with NUS Yong Loo Lin School of Medicine and Duke-NUS Medical School.
Its current official research list spans AI and digital health, bioengineering and devices, major clinical eye fields, epidemiology, imaging, drug delivery, population health, regenerative therapy and visual neuroscience.
Did you know? The retina is the only place where clinicians can directly image small blood vessels and neural tissue together without surgery, making eye images useful for both vision research and carefully validated studies of wider health.
SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions. This guide separates current published facts from practical learning advice. Programme details were checked on 28 October 2026; families and students should recheck the linked official pages before applying, paying or attending.
Chapter index
Chapters 1–9: eye optics, visual acuity, myopia, longitudinal studies, cohorts, imaging, OCT, AI evaluation and glaucoma
- 1. The eye is an optical and biological system
- 2. Visual acuity is one outcome, not all of vision
- 3. Myopia research follows eye growth and risk
- 4. Longitudinal studies separate age from change
- 5. Population cohorts make denominators visible
- 6. Eye imaging turns structure into quantitative data
- 7. OCT uses reflected light to map tissue layers
- 8. Artificial intelligence needs task-specific evaluation
- 9. Sensitivity and specificity describe different errors
Chapters 10–17: retina, cornea, therapeutics, devices, clinical trials, ethics, translation, evidence receipts and careers
- 10. Glaucoma research joins structure, pressure and function
- 11. Retina research studies neural and vascular tissue
- 12. Cornea and ocular surface research spans optics and biology
- 13. Therapeutics and drug delivery must reach the target safely
- 14. Bioengineering converts needs into testable devices
- 15. Clinical trials protect participants and comparisons
- 16. Data governance protects people and validity
- 17. Keep a vision-research evidence receipt
CHAPTER 1 OF 17 · Understand vision measurement
1. The eye is an optical and biological system
The cornea and lens focus light onto the retina, which transforms it into neural signals. Tear film, pupil, ocular shape, retinal cells and brain processing all influence measured vision.
Vision research connects optics, neuroscience, imaging, epidemiology, engineering and clinical care. A useful finding must remain valid across instruments, populations, disease stages and real patient workflows. The practical capability is vision-science literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “The eye is an optical and biological system” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A refractive measurement does not describe every cause of visual difficulty.
Try this now
Build a dated evidence card for “The eye is an optical and biological system” with the question, method, observation, limitation and next test. Label the result with the date and the capability “vision-science literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A refractive measurement does not describe every cause of visual difficulty.
CHAPTER 2 OF 17 · Understand vision measurement
2. Visual acuity is one outcome, not all of vision
Letter charts estimate spatial resolution under specified distance, contrast and correction. Contrast sensitivity, fields, colour, depth and real-world tasks can reveal other limitations.
Eye studies often follow people over time because prevalence, onset, progression and treatment response answer different questions. Cohort design and retention affect which conclusions the data can support. The practical capability is functional measurement. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Visual acuity is one outcome, not all of vision” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A single acuity score does not capture every visual function.
Field-note prompt
Build a dated evidence card for “Visual acuity is one outcome, not all of vision” with the question, method, observation, limitation and next test. Label the result with the date and the capability “functional measurement”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A single acuity score does not capture every visual function.
CHAPTER 3 OF 17 · Understand vision measurement
3. Myopia research follows eye growth and risk
Myopia occurs when optical focus and eye geometry are mismatched, commonly with excessive axial length. Studies examine genetics, environment, progression, imaging and interventions across childhood and adulthood.
Images become evidence through acquisition standards, grading rules, quality checks and clinical reference labels. Artificial intelligence can assist analysis only within the population and task for which it has been evaluated. The practical capability is myopia literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Myopia research follows eye growth and risk” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Population findings do not determine an individual treatment plan.
Learning move
Build a dated evidence card for “Myopia research follows eye growth and risk” with the question, method, observation, limitation and next test. Label the result with the date and the capability “myopia literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Population findings do not determine an individual treatment plan.
CHAPTER 4 OF 17 · Understand vision measurement
4. Longitudinal studies separate age from change
Following participants over time can estimate incidence and progression rather than only prevalence. Visit timing, measurement consistency, loss to follow-up and changing exposures affect conclusions.
Translation in ophthalmology is staged. Mechanism, prototype performance, safety, clinical validity, usefulness and adoption each require different evidence and oversight before a tool changes care. The practical capability is longitudinal reasoning. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Longitudinal studies separate age from change” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A cross-sectional age difference is not automatically an ageing trajectory.
Evidence practice
Build a dated evidence card for “Longitudinal studies separate age from change” with the question, method, observation, limitation and next test. Label the result with the date and the capability “longitudinal reasoning”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A cross-sectional age difference is not automatically an ageing trajectory.
CHAPTER 5 OF 17 · Study populations and progression
5. Population cohorts make denominators visible
SERI’s official SEED programme combines large studies of major eye diseases and risk factors in Asian populations. Sampling, eligibility and participation determine which wider population the results can represent.
Vision research connects optics, neuroscience, imaging, epidemiology, engineering and clinical care. A useful finding must remain valid across instruments, populations, disease stages and real patient workflows. The practical capability is epidemiology literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Population cohorts make denominators visible” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A clinic sample may not estimate community prevalence.
Try this now
Build a dated evidence card for “Population cohorts make denominators visible” with the question, method, observation, limitation and next test. Label the result with the date and the capability “epidemiology literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A clinic sample may not estimate community prevalence.
CHAPTER 6 OF 17 · Study populations and progression
6. Eye imaging turns structure into quantitative data
Fundus photography, optical coherence tomography and other modalities reveal different tissues and depths. Focus, segmentation, device settings and grader rules influence measurements and comparisons.
Eye studies often follow people over time because prevalence, onset, progression and treatment response answer different questions. Cohort design and retention affect which conclusions the data can support. The practical capability is ophthalmic-imaging literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Eye imaging turns structure into quantitative data” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A high-resolution image is not a diagnosis without clinical interpretation.
Field-note prompt
Build a dated evidence card for “Eye imaging turns structure into quantitative data” with the question, method, observation, limitation and next test. Label the result with the date and the capability “ophthalmic-imaging literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A high-resolution image is not a diagnosis without clinical interpretation.
CHAPTER 7 OF 17 · Study populations and progression
7. OCT uses reflected light to map tissue layers
Optical coherence tomography reconstructs depth-resolved retinal or anterior-segment structure from interferometric signals. Motion, media opacity and segmentation errors can create artefacts.
Images become evidence through acquisition standards, grading rules, quality checks and clinical reference labels. Artificial intelligence can assist analysis only within the population and task for which it has been evaluated. The practical capability is OCT reasoning. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “OCT uses reflected light to map tissue layers” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An automated thickness value should be checked against image quality and anatomy.
Learning move
Build a dated evidence card for “OCT uses reflected light to map tissue layers” with the question, method, observation, limitation and next test. Label the result with the date and the capability “OCT reasoning”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: An automated thickness value should be checked against image quality and anatomy.
CHAPTER 8 OF 17 · Study populations and progression
8. Artificial intelligence needs task-specific evaluation
An eye-image model may detect, segment, classify or predict. Developers must define the target condition, reference standard, population, threshold and workflow, then test calibration and external performance.
Translation in ophthalmology is staged. Mechanism, prototype performance, safety, clinical validity, usefulness and adoption each require different evidence and oversight before a tool changes care. The practical capability is clinical-AI literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Artificial intelligence needs task-specific evaluation” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Strong performance in one dataset does not guarantee safe use elsewhere.
Evidence practice
Build a dated evidence card for “Artificial intelligence needs task-specific evaluation” with the question, method, observation, limitation and next test. Label the result with the date and the capability “clinical-AI literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Strong performance in one dataset does not guarantee safe use elsewhere.
CHAPTER 9 OF 17 · Evaluate images, AI and mechanisms
9. Sensitivity and specificity describe different errors
Sensitivity tracks detected cases while specificity tracks correctly excluded non-cases. Predictive values also depend on prevalence, and thresholds trade missed cases against false alarms.
Vision research connects optics, neuroscience, imaging, epidemiology, engineering and clinical care. A useful finding must remain valid across instruments, populations, disease stages and real patient workflows. The practical capability is diagnostic-test reasoning. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Sensitivity and specificity describe different errors” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: One accuracy percentage can hide clinically important error patterns.
Try this now
Build a dated evidence card for “Sensitivity and specificity describe different errors” with the question, method, observation, limitation and next test. Label the result with the date and the capability “diagnostic-test reasoning”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: One accuracy percentage can hide clinically important error patterns.
CHAPTER 10 OF 17 · Evaluate images, AI and mechanisms
10. Glaucoma research joins structure, pressure and function
Glaucoma can involve optic-nerve damage and visual-field loss, while pressure is one important risk factor rather than the disease itself. Imaging, fields, anatomy and longitudinal change contribute to assessment.
Eye studies often follow people over time because prevalence, onset, progression and treatment response answer different questions. Cohort design and retention affect which conclusions the data can support. The practical capability is glaucoma literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Glaucoma research joins structure, pressure and function” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: One pressure reading cannot confirm or exclude glaucoma.
Field-note prompt
Build a dated evidence card for “Glaucoma research joins structure, pressure and function” with the question, method, observation, limitation and next test. Label the result with the date and the capability “glaucoma literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: One pressure reading cannot confirm or exclude glaucoma.
CHAPTER 11 OF 17 · Evaluate images, AI and mechanisms
11. Retina research studies neural and vascular tissue
Retinal imaging and functional tests support research on diabetic retinopathy, age-related macular degeneration and other conditions. Disease stage, systemic factors and imaging protocol shape interpretation.
Images become evidence through acquisition standards, grading rules, quality checks and clinical reference labels. Artificial intelligence can assist analysis only within the population and task for which it has been evaluated. The practical capability is retinal-science reasoning. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Retina research studies neural and vascular tissue” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A retinal image can suggest patterns but does not replace complete clinical assessment.
Learning move
Build a dated evidence card for “Retina research studies neural and vascular tissue” with the question, method, observation, limitation and next test. Label the result with the date and the capability “retinal-science reasoning”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A retinal image can suggest patterns but does not replace complete clinical assessment.
CHAPTER 12 OF 17 · Evaluate images, AI and mechanisms
12. Cornea and ocular surface research spans optics and biology
Transparency, curvature, nerves, epithelium, tear film and immune responses affect comfort and vision. Laboratory, imaging and clinical outcomes may move differently and need separate measures.
Translation in ophthalmology is staged. Mechanism, prototype performance, safety, clinical validity, usefulness and adoption each require different evidence and oversight before a tool changes care. The practical capability is corneal-science literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Cornea and ocular surface research spans optics and biology” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Symptom severity may not match one surface test.
Evidence practice
Build a dated evidence card for “Cornea and ocular surface research spans optics and biology” with the question, method, observation, limitation and next test. Label the result with the date and the capability “corneal-science literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Symptom severity may not match one surface test.
CHAPTER 13 OF 17 · Translate safely into eye care
13. Therapeutics and drug delivery must reach the target safely
Drops, injections, implants and other approaches face barriers of penetration, residence time, dosing and toxicity. Preclinical evidence, formulation and staged trials address different risks.
Vision research connects optics, neuroscience, imaging, epidemiology, engineering and clinical care. A useful finding must remain valid across instruments, populations, disease stages and real patient workflows. The practical capability is ocular-therapeutics reasoning. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Therapeutics and drug delivery must reach the target safely” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A biological mechanism does not establish a safe or effective treatment.
Try this now
Build a dated evidence card for “Therapeutics and drug delivery must reach the target safely” with the question, method, observation, limitation and next test. Label the result with the date and the capability “ocular-therapeutics reasoning”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A biological mechanism does not establish a safe or effective treatment.
CHAPTER 14 OF 17 · Translate safely into eye care
14. Bioengineering converts needs into testable devices
Imaging hardware, sensors, surgical tools and assistive systems begin with a defined user and workflow. Bench tests, human factors, reliability and clinical evaluation build evidence in stages.
Eye studies often follow people over time because prevalence, onset, progression and treatment response answer different questions. Cohort design and retention affect which conclusions the data can support. The practical capability is ophthalmic-engineering literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Bioengineering converts needs into testable devices” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A working prototype is not an approved medical device.
Field-note prompt
Build a dated evidence card for “Bioengineering converts needs into testable devices” with the question, method, observation, limitation and next test. Label the result with the date and the capability “ophthalmic-engineering literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: A working prototype is not an approved medical device.
CHAPTER 15 OF 17 · Translate safely into eye care
15. Clinical trials protect participants and comparisons
Protocols define eligibility, intervention, comparator, outcomes, monitoring and analysis. Randomisation, masking and preregistration can reduce bias, while ethics review and consent protect participants.
Images become evidence through acquisition standards, grading rules, quality checks and clinical reference labels. Artificial intelligence can assist analysis only within the population and task for which it has been evaluated. The practical capability is clinical-trial literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Clinical trials protect participants and comparisons” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Trial participation and treatment decisions require qualified clinical guidance.
Learning move
Build a dated evidence card for “Clinical trials protect participants and comparisons” with the question, method, observation, limitation and next test. Label the result with the date and the capability “clinical-trial literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Trial participation and treatment decisions require qualified clinical guidance.
CHAPTER 16 OF 17 · Translate safely into eye care
16. Data governance protects people and validity
Eye images, genetics and health records can be sensitive. Consent, authorised access, de-identification, security, provenance and retention rules support both participant rights and reproducible research.
Translation in ophthalmology is staged. Mechanism, prototype performance, safety, clinical validity, usefulness and adoption each require different evidence and oversight before a tool changes care. The practical capability is research-ethics literacy. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Data governance protects people and validity” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Removing a name may not eliminate re-identification risk.
Evidence practice
Build a dated evidence card for “Data governance protects people and validity” with the question, method, observation, limitation and next test. Label the result with the date and the capability “research-ethics literacy”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Removing a name may not eliminate re-identification risk.
CHAPTER 17 OF 17 · Translate safely into eye care
17. Keep a vision-research evidence receipt
Archive protocol, consent and approvals, cohort, device and software version, calibration, image quality, reference grading, outcomes, exclusions, subgroup results, uncertainty and decision stage. Students can learn from public evidence while clinicians manage care.
Vision research connects optics, neuroscience, imaging, epidemiology, engineering and clinical care. A useful finding must remain valid across instruments, populations, disease stages and real patient workflows. The practical capability is vision-science career preparation. Keep the question, method, controls, observation, uncertainty, review and next decision in one evidence receipt. That record makes progress visible without enlarging the claim beyond the stage reached. SERI, SNEC and study teams control current research, recruitment and released findings; clinicians and health authorities control diagnosis, treatment, trials and patient-care decisions.
Put this into practice by turning the idea into a small, reviewable action: Build a dated evidence card for “Keep a vision-research evidence receipt” with the question, method, observation, limitation and next test. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Only current clinicians, institutions and regulators can diagnose, prescribe, recruit or authorise a product.
Try this now
Build a dated evidence card for “Keep a vision-research evidence receipt” with the question, method, observation, limitation and next test. Label the result with the date and the capability “vision-science career preparation”.
An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.
Evidence checkpoint
Can another person trace the claim to a current source, observation or documented decision? Keep this boundary visible: Only current clinicians, institutions and regulators can diagnose, prescribe, recruit or authorise a product.
Vision-research evidence chain
| Stage | Evidence to keep | Boundary to retain |
|---|---|---|
| Question | Population, eye condition, outcome and time | A broad vision claim needs a defined cohort |
| Measurement | Refraction, imaging, function and quality control | Different tests measure different constructs |
| Evaluation | Comparator, masking, uncertainty and subgroup analysis | Accuracy alone does not show clinical benefit |
| Translation | Safety, usefulness, workflow, ethics and authority | Research is not personal medical advice |
Science learning becomes useful when a student can show where a claim came from, why it applies and where it stops. Continue with the eduKate Science Learning Hub, compare choices in the Education Hub, and connect developing capabilities to education and career pathways. Families looking for science tuition or a science tutor can use the same evidence questions: what will the learner practise, what feedback will they receive, and how will progress be shown?
Turn vision into measurable evidence—connecting optics, myopia, cohorts, imaging, artificial intelligence, glaucoma, retina, cornea, therapeutics, devices, trials and patient-centred translation The happiest outcome is not a perfect label. It is a learner who can ask a sharper question, work safely, notice honestly, revise with feedback and stay curious about what comes next.
Primary sources and verification date
Source status checked 28 October 2026. Programme rules, dates, eligibility, access and participation routes can change; use the linked official owner for the current edition.
- Singapore National Eye Centre: About SERI — Official description of SERI’s 1997 establishment, national remit, mission, affiliations and current institutional profile; quantitative profile dated October 2025.
- Singapore National Eye Centre: SERI Research Groups and Platforms — Official current list of research groups spanning AI, devices, clinical fields, epidemiology, imaging, therapeutics and visual neuroscience.
- Singapore National Eye Centre: Myopia Research Group — Official programme scope covering epidemiology, genetics, models, interventions and pathologic myopia; study details must be read in context.
- Singapore National Eye Centre: Singapore Epidemiology of Eye Diseases — Official SEED aims, cohorts, diseases studied and population-research competencies.
- SingHealth Research and Innovation — Official SingHealth overview identifying SERI and its high-impact research on eye diseases relevant to Singaporeans and Asians.
